IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-3-319-52636-2_107.html
   My bibliography  Save this book chapter

Platform Trial Designs

In: Principles and Practice of Clinical Trials

Author

Listed:
  • Oleksandr Sverdlov

    (Novartis Pharmaceuticals Corporation)

  • Ekkehard Glimm

    (Novartis Pharma AG)

  • Peter Mesenbrink

    (Novartis Pharmaceuticals Corporation)

Abstract

Modern drug development is increasingly complex and requires novel approaches to the design and analysis of clinical trials. With the precision medicine paradigm, there is a strong need to evaluate multiple experimental therapies across a spectrum of indications, in different subgroups of patients, while controlling the chance of false positive and false negative findings. The concept of master protocols provides a new approach to clinical trial design that can help drug developers to enhance efficiency of clinical trials by addressing multiple research questions within the same overall trial infrastructure. There are three general types of trials requiring a master protocol: basket trials, umbrella trials, and platform trials. The present chapter provides an overview of platform trial designs. We discuss operating models for implementing platform trials in practice, as well as some important statistical considerations for design and analysis of such trials. We also discuss four real-life examples of platform trials: the EPAD-PoC study in Alzheimer’s disease; the I-SPY COVID-19 study for rapid screening of re-purposed and novel treatments for COVID-19; the GBM AGILE study in glioblastoma; and the FOCUS4 study in metastatic colorectal cancer.

Suggested Citation

  • Oleksandr Sverdlov & Ekkehard Glimm & Peter Mesenbrink, 2022. "Platform Trial Designs," Springer Books, in: Steven Piantadosi & Curtis L. Meinert (ed.), Principles and Practice of Clinical Trials, chapter 76, pages 1455-1485, Springer.
    • Handle: RePEc:spr:sprchp:978-3-319-52636-2_107
    DOI: 10.1007/978-3-319-52636-2_107
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a
    for a similarly titled item that would be available.

    More about this item

    Keywords

    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-3-319-52636-2_107. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.